Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Merck
Queensland Health
Cipla
Dow
US Department of Justice
Baxter
US Army
McKinsey
Boehringer Ingelheim

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202719

« Back to Dashboard

NDA 202719 describes BIMATOPROST, which is a drug marketed by Apotex Inc, Lupin Ltd, and Sandoz Inc, and is included in five NDAs. It is available from three suppliers. Additional details are available on the BIMATOPROST profile page.

The generic ingredient in BIMATOPROST is bimatoprost. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the bimatoprost profile page.
Summary for 202719
Tradename:BIMATOPROST
Applicant:Sandoz Inc
Ingredient:bimatoprost
Patents:0
Therapeutic Class:Ophthalmic Agents
Pharmacology for NDA: 202719
Ingredient-typeProstaglandins
Medical Subject Heading (MeSH) Categories for 202719
Suppliers and Packaging for NDA: 202719
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BIMATOPROST bimatoprost SOLUTION/DROPS;TOPICAL 202719 ANDA Sandoz Inc 0781-6206 0781-6206-75 5 mL in 1 BOTTLE (0781-6206-75)
BIMATOPROST bimatoprost SOLUTION/DROPS;TOPICAL 202719 ANDA Sandoz Inc 0781-6206 0781-6206-93 3 mL in 1 BOTTLE (0781-6206-93)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;TOPICALStrength0.03%
Approval Date:Apr 19, 2016TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Novartis
Healthtrust
UBS
Federal Trade Commission
Harvard Business School
Baxter
Argus Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot